IndraLab

Statements


USP43 activates EOC. 3 / 3
| 3

reach
"In EOC, USP43 promotes the proliferation and impairs cisplatin sensitivity."

reach
"The study delves into the tumor-promoting impact in EOC, showing that USP43 enhances the proliferation, invasion, and migration of EOC, and facilitates EOC cells to enter the cell cycle’s proliferation phase.Cisplatin is a primary chemotherapeutic treatment for EOC."

reach
"USP43 promoted cell proliferation, migration, invasion and chemoresistance of EOC."